Pancreatic Cancer Research

ResearcherUniversity of WestminsterActive in the last 2 years

Pinar Uysal Onganer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-3190-8831; OpenAlex author ID A5025609833. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
44
Papers, trials and grants by year

2021: 3 papers · 2022: 3 papers · 2023: 2 papers · 2024: 1 paper · 2025: 3 papers · 2026: 2 papers

Papers 14

  1. Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives. Co-author DOI 10.1016/j.biopha.2026.119394↗
  2. Chemopreventive Effects of Lycopene in miR-21 Knockout and Wild-Type Pancreatic Cancer Cells. Co-author DOI 10.1155/sci5/8865270↗
  3. Perineural Invasion in Pancreatic Ductal Adenocarcinoma: Recapitulating Its Importance and Defining Future Directions. Last author DOI 10.1002/ueg2.70118↗
  4. Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2025.02.009↗
  5. The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC. Co-author DOI 10.1016/j.semcancer.2025.05.004↗
  6. miR-210 Mediated Hypoxic Responses in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1021/acsomega.4c08947↗
  7. Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21. Last author DOI 10.1016/j.ejcb.2023.151318↗
  8. Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer. Last author DOI 10.3390/cimb45120611↗
  9. Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00204-021-03196-9↗
  10. microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells. Last author DOI 10.3390/ijms23031275↗
  11. Nickel's Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs. Last author DOI 10.3390/toxics10030148↗
  12. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. Last author DOI 10.1016/j.tranon.2021.101090↗
  13. The Role of CDK4 in the Pathogenesis of Pancreatic Cancer. Last author DOI 10.3390/healthcare9111478↗
  14. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles f… Co-author DOI 10.3390/ijms22031396↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maria Mortoglou · 9 shared papers, 2021–2024 · strength 1.85
  2. Elif Damla Arısan · 3 shared papers, 2021–2026 · strength 0.70
  3. Daniele Campa · 3 shared papers, 2025–2026 · strength 0.60
  4. Mutian Lian · 2 shared papers, 2023–2024 · strength 0.59
  5. Neil Daniel · 2 shared papers, 2025–2026 · strength 0.43
  6. David J. Hughes · 2 shared papers, 2025–2026 · strength 0.43
  7. Juan Sáinz · 2 shared papers, 2025–2026 · strength 0.43
  8. Giulia Peduzzi · 2 shared papers, 2025 · strength 0.37
  9. Cosmeri Rizzato · 2 shared papers, 2025 · strength 0.37
  10. Pınar Obakan Yerlikaya · 1 shared paper, 2026 · strength 0.36
  11. Başak Dalbayrak · 1 shared paper, 2026 · strength 0.36
  12. Sigrun Lange · 2 shared papers, 2021–2022 · strength 0.35
  13. Aleksandra Buha Djordjević · 2 shared papers, 2022 · strength 0.32
  14. David Wallace · 2 shared papers, 2022 · strength 0.32
  15. Martin Loveček · 1 shared paper, 2025 · strength 0.25
  16. Ingrid Garajová · 1 shared paper, 2025 · strength 0.25
  17. Giulia Gasparini · 1 shared paper, 2025 · strength 0.25
  18. Carmen Mota Reyes · 1 shared paper, 2025 · strength 0.25
  19. Elisa Giovannetti · 1 shared paper, 2025 · strength 0.25
  20. İhsan Ekin Demir · 1 shared paper, 2025 · strength 0.25
  21. Stefano Crippa · 1 shared paper, 2025 · strength 0.25
  22. María Carretero-Fernández · 1 shared paper, 2026 · strength 0.23
  23. Annalisa Comandatore · 1 shared paper, 2025 · strength 0.20
  24. Riccardo Farinella · 1 shared paper, 2025 · strength 0.20
  25. Ruggero Ponz de Leon Pisani · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.